Table 2.
Representative multiphoton biosensors papers for the detection of SARS-CoV-2.
Journal | Detection Limit | Analyte Types | Optical Effect | Year | Reference |
---|---|---|---|---|---|
IEEE Sensors Journal | 2.5 ng/mL | Nucleocapsid protein | Plasmonic fiber optic absorbance | 2021 | [108] |
Biosensors | 0.047 μg/mL | SARS-CoV-2 pseudovirus | Surface plasmon resonance | 2022 | [109] |
Biosensors and Bioelectronics | Spike protein | Raman scattering | 2021 | [110] | |
Sensors and Actuators B: Chemical | 50 and 10 pfu/mL | Angiotensin-converting enzyme 2 | Raman scattering | 2022 | [111] |
ECS Meeting Abstracts | - | Antibodies to SARS-CoV-2 | Surface plasmon resonance | 2021 | [112] |
Analytical Chemistry | Nucleocapsid protein | Plasmonics | 2022 | [21] | |
Biosensors and Bioelectronics | 2 ng/spot | spike S1, spike S1 S2, and the nucleocapsid protein | Fluorescent plasmonics | 2021 | [113] |
Sensors | 4.2 μg/mL | Spike protein | Photonics | 2021 | [114] |
Analyst | Spike S1 protein | Surface plasmon resonance | 2022 | [115] | |
Biomedical Vibrational Spectroscopy 2022: Advances in Research and Industry | - | Spike protein | Raman spectroscopy | 2022 | [116] |
Plasmonics | 152°/RIU | Spike proteins, membrane proteins, envelop proteins, and nucleoprotein | Surface plasmon resonance | 2022 | [117] |
Sensors | 250 μg/mL | Spike (S1 and S2) proteins | Surface plasmon resonance | 2021 | [118] |
IEEE SENSORS 2021 | 8.34 ng/mL | Spike protein | Surface plasmon resonance | 2021 | [119] |
Biosensors and Bioelectronics | 1 μg/mL | Nucleocapsid antibody | Surface plasmon resonance | 2022 | [120] |
AIP Advances | Spike glycoprotein | Surface plasmon resonance | 2021 | [67] | |
Analytical Chemistry | - | Spike surface glycoprotein | Surface-enhanced infrared absorption | 2021 | [13] |
Matter | 10 PFU/mL | Spike glycoprotein and membrane protein | Raman scattering | 2022 | [121] |
ACS Applied Nano Materials | 200 PFU/mL | Spike proteins | Raman scattering | 2022 | [122] |
ACS Nano | 0.22 pM | RNA-dependent RNA polymerase | Localized surface plasmon resonance | 2020 | [123] |
Analytical Chemistry | - | Angiotensin-converting enzyme 2 | Surface plasmon resonance | 2020 | [124] |
Biosensors and Bioelectronics | 150 ng/ml | Detect SARS-CoV-2 nucleocapsid proteins | Localized surface Plasmon resonance | 2022 | [125] |
Analytical Methods | 200 μL | Spike and nucleocapsid proteins | Surface plasmon resonance | 2021 | [126] |
Sensors & Diagnostics | 10 RU | Spike protein | Surface plasmon resonance | 2022 | [127] |
Biosensors and Bioelectronics | particles/mL | Nucleocapsid phosphoprotein gene | Raman scattering | 2022 | [128] |
BioChip Journal | 1.02 pM | Antibodies against nucleoprotein | Surface plasmon resonance | 2020 | [129] |
Nanoscale Advances | SARS-CoV-2 spike protein | Raman scattering | 2022 | [130] | |
Biosensors and Bioelectronics | 0.08 ng/mL | SARS-CoV-2 spike protein | Localized surface plasmon resonance | 2020 | [131] |
Analytical Chemistry | 4 mg/mL | SARS-CoV-2 spike protein | Surface plasmon resonance | 2021 | [132] |
Plasmonics | Thiol-tethered DNA of SARS-CoV-2 | Surface plasmon resonance | 2021 | [133] | |
Talanta | 0.046 ng/mL | SARS-CoV-2 spike protein | Raman scattering | 2022 | [134] |
Talanta | Measurement of SARS-CoV-2 antibody | Photonic resonator absorption | 2021 | [135] | |
Talanta | 37 nM | SARS-CoV-2 spike glycoprotein | Surface plasmon resonance | 2021 | [136] |